According to a white-frost & S...

According to a white-frost & Sullivan report, the gap between capacity and demand in biopharmaceutical production will narrow athwart the next several years. The report--Quantitative Analysis of Global Biopharmaceutical Manufacturing--estimates that sole 60% of existing capacity is commonly being utilized. Utilization is count uponed to increase to approximately 85% by means of 2011 due to the approval of medicines now in development. In the coming events relative undercapacity may significantly impede industry progres Other issues discussed in the report include resource and portfolio